119 related articles for article (PubMed ID: 25356939)
21. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
Foo WC; Jo VY; Krane JF
Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
[TBL] [Abstract][Full Text] [Related]
23. Detection of BRAF mutations on direct smears of thyroid fine-needle aspirates through cell transfer technique.
Shi Q; Ibrahim A; Herbert K; Carvin M; Randolph M; Post KM; Curless K; Chen S; Cramer HM; Cheng L; Wu HH
Am J Clin Pathol; 2015 Apr; 143(4):500-4. PubMed ID: 25780001
[TBL] [Abstract][Full Text] [Related]
24. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
25. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Ann Surg; 2005 Sep; 242(3):353-61; discussion 361-3. PubMed ID: 16135921
[TBL] [Abstract][Full Text] [Related]
26. Utility of fine-needle aspiration for diagnosis of carcinoma associated with multinodular goitre.
Ríos A; Rodríguez JM; Galindo PJ; Montoya M; Tebar FJ; Sola J; Canteras M; Parrilla P
Clin Endocrinol (Oxf); 2004 Dec; 61(6):732-7. PubMed ID: 15579188
[TBL] [Abstract][Full Text] [Related]
27. [A standardized protocol for detection of ALK protein expression and gene fusion in lung adenocarcinoma cytologic specimens].
Wang Z; Wu X; Shi Y; Han X; Cheng G; Li L; Mu X; Zhang Y; Cui D; Zhang L; Fan Z; Zhu G; Ma L; Yang L; Di J; Liu D
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):742-8. PubMed ID: 26813592
[TBL] [Abstract][Full Text] [Related]
28. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC
Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962
[TBL] [Abstract][Full Text] [Related]
29. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
[TBL] [Abstract][Full Text] [Related]
30. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.
Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP
J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809
[TBL] [Abstract][Full Text] [Related]
31. Measurement of fine-needle aspiration thyroglobulin levels increases the detection of metastatic papillary thyroid carcinoma in cystic neck lesions.
Holmes BJ; Sokoll LJ; Li QK
Cancer Cytopathol; 2014 Jul; 122(7):521-6. PubMed ID: 24591483
[TBL] [Abstract][Full Text] [Related]
32. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of fine-needle aspiration cytology of lesions involving bone.
Yu GH; Maisel J; Frank R; Pukenas BA; Sebro R; Weber K
Diagn Cytopathol; 2017 Jul; 45(7):608-613. PubMed ID: 28470965
[TBL] [Abstract][Full Text] [Related]
34. Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001-2007: an institutional experience of 1,945 cases.
Seningen JL; Nassar A; Henry MR
Diagn Cytopathol; 2012 May; 40 Suppl 1():E27-32. PubMed ID: 22619156
[TBL] [Abstract][Full Text] [Related]
35. Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine-needle aspirate samples.
Dyhdalo K; Macnamara S; Brainard J; Underwood D; Tubbs R; Yang B
Cancer Cytopathol; 2014 Feb; 122(2):114-22. PubMed ID: 24150898
[TBL] [Abstract][Full Text] [Related]
36. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
37. CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.
Li W; Xia S; Aronova A; Min IM; Verma A; Scognamiglio T; Gray KD; Ullmann TM; Liang H; Moore MD; Elemento O; Zarnegar R; Fahey TJ
J Surg Oncol; 2018 Nov; 118(6):1042-1049. PubMed ID: 30311656
[TBL] [Abstract][Full Text] [Related]
38. Use of a thin-layer technique in thyroid fine needle aspiration.
Malle D; Valeri RM; Pazaitou-Panajiotou K; Kiziridou A; Vainas I; Destouni C
Acta Cytol; 2006; 50(1):23-7. PubMed ID: 16514836
[TBL] [Abstract][Full Text] [Related]
39. Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer.
Wagner K; Arciaga R; Siperstein A; Milas M; Warshawsky I; Sethu S; Reddy K; Gupta MK
J Clin Endocrinol Metab; 2005 Apr; 90(4):1921-4. PubMed ID: 15687333
[TBL] [Abstract][Full Text] [Related]
40. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
